# US 2021/0277385 A1 · Method for editing dna in cell-free system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277385 A1
- Document ID: US20210277385A1
- Status: Published application
- Kind: A1
- Application number: 17/260,071
- Filed: 2019-07-30
- Published: 2021-09-09
- Earliest claimed: 2018-07-30
- Assignees: OriCiro Genomics, Inc.
- Applicants: OriCiro Genomics, Inc.
- Inventors: Masayuki SUETSUGU; Ayako TAWARAGI; Koki KANOH
- Web page: https://patentgrep.com/patent/US20210277385A1

## CPC

- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 15/102: {Mutagenizing nucleic acids}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6844: Nucleic acid amplification reactions
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A method for editing DNA in a cell-free system, the method including: (1) a step of introducing a deletion, substitution or addition at a target site of a DNA in a cell-free system, and (2) a step of amplifying, in a cell-free system, the DNA into which a deletion, substitution or addition has been introduced in step (1), wherein the DNA is amplified under temperature conditions that incubate at a temperature within a range from 20° C. to 80° C.

## Claims

### Claim 1

A method for editing DNA in a cell-free system, the method comprising the following steps:
(1) a step of introducing a deletion, substitution or addition at a target site of a DNA in a cell-free system, and
(2) a step of amplifying, in a cell-free system, the DNA into which a deletion, substitution or addition has been introduced in step (1), wherein the DNA is amplified under temperature conditions that incubate at a temperature within a range from 20° C. to 80° C.

### Claim 2 (depends on 1)

The method for editing DNA in a cell-free system according to claim 1, the method comprising the following steps:
(1) a step of introducing a deletion, substitution or addition at a target site of a DNA in a cell-free system, and
(2) a step of amplifying, in a cell-free system, the DNA into which a deletion, substitution or addition has been introduced in step (1), wherein the DNA is amplified under temperature conditions that either incubate at a constant temperature, or incubate under a repeating temperature cycle in which incubation is conducted at two temperatures of 65° C. or lower.

### Claim 3 (depends on 1)

The method for editing DNA in a cell-free system according to claim 1, the method comprising the following steps:
(1) a step of introducing a deletion, substitution or addition at a target site of a DNA in a cell-free system, and
(2) a step of amplifying, in a cell-free system, the DNA into which a deletion, substitution or addition has been introduced in step (1), wherein the DNA is amplified under temperature conditions that either incubate at a fixed temperature within a range from 20° C. to 80° C., or incubate under a repeating temperature cycle in which incubation is conducted at two temperatures of 65° C. or lower.

### Claim 4 (depends on 1)

The method according to claim 1, wherein step (2) is conducted in presence of an artificial DNA cleavage enzyme that specifically cleaves DNA into which a deletion, substitution or addition has not been introduced.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the artificial DNA cleavage enzyme is an artificial nuclease or an RNA-guided nuclease.

### Claim 6 (depends on 4)

The method according to claim 4, wherein the artificial DNA cleavage enzyme is CRISPR-Cas9.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the DNA is a circular DNA.

### Claim 8 (depends on 7)

The method according to claim 7, wherein step (2) comprises the following steps:
(2-1) a step of preparing a reaction mixture of: a reaction solution comprising (a) a first enzyme group that catalyzes replication of the circular DNA, (b) a second enzyme group that catalyzes an Okazaki fragment ligation reaction and synthesizes two sister circular DNAs that form a catenane, and (c) a third enzyme group that catalyzes a separation reaction of the two sister circular DNAs; and the circular DNA into which a deletion, substitution or addition has been introduced in step (1); and
(2-2) a step of incubating the reaction mixture prepared in step (2-1), either at a fixed temperature within a range from 20° C. to 80° C., or under a repeating temperature cycle in which incubation is conducted at two temperatures of 65° C. or lower.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the circular DNA contains a replication origin sequence that can bind to an enzyme having DnaA activity.

### Claim 10 (depends on 7)

The method according to claim 7, wherein in step (2), the circular DNA is amplified by rolling circle amplification.

### Claim 11 (depends on 1)

The method according to claim 1, wherein step (1) comprises the following steps:
(1-1) a step of cleaving the DNA at a target site to prepare at least one linear DNA by causing an artificial DNA cleavage enzyme to act upon the DNA;
(1-2) a step of preparing a reaction solution containing the linear DNA prepared in step (1-1), one or more types of DNA fragment, and a protein having RecA family recombinase activity; and
(1-3) a step of mutually joining the linear DNA and the one or more types of DNA fragment at regions in which base sequences are homologous or at regions in which base sequences are complementary, thereby forming a DNA in which the one or more types of DNA fragment have each been inserted at a target site of a template DNA.

### Claim 12 (depends on 1)

The method according to claim 1, wherein step (1) comprises the following step:
a step of conducting a DNA replication reaction in presence of a single-stranded DNA used for introducing a deletion, substitution or addition, wherein the single-stranded DNA can hybridize with a target site of the DNA under the replication reaction conditions.

### Claim 13 (depends on 1)

The method according tom claim 1, wherein in step (2), the DNA is amplified under temperature conditions that incubate under a temperature cycle that repeats incubation at 30° C. or higher and incubation at 27° C. or lower.

### Claim 14 (depends on 1)

The method according tom claim 1, wherein a size of the DNA into which a deletion, substitution or addition has been introduced is 50 kb or larger.
